Alder Biopharma

FDA accepts BLA for Alder's migraine therapy for infusion
BioCentury
Mon, 04/22/19 - 06:59 pm
Alder Biopharma
FDA
eptinezumab
migraines
This little biotech has so much going against it, somebody is going to want to buy it. Right?
Endpoints
Mon, 01/14/19 - 10:39 am
Alder Biopharma
M&A
Alder prices $150M offering to fund migraine market scrap
Fierce Biotech
Thu, 07/13/17 - 05:33 pm
Alder Biopharma
migraines
eptinezumab
Little Alder bags positive PhIII migraine data, but giant rivals are racing ahead in a crowded field
Endpoints
Tue, 06/27/17 - 09:38 am
Alder Biopharma
migraines
clinical trials
eptinezumab
Eli Lilly
Amgen
Novartis
Merck
The drug industry might finally have an answer for migraines
Stat
Fri, 09/23/16 - 09:52 am
migraines
Amgen
Eli Lilly
Alder Biopharma
Teva Pharmaceutical
CGRP blockers
The Pharma Industry Thinks It Finally Has a Fix for Migraines
Yahoo/Bloomberg
Tue, 07/21/15 - 10:17 am
migraines
Teva Pharmaceutical
Amgen
Eli Lilly
Alder Biopharma
CGRPs
Bristol-Myers dumps $1B-plus Alder deal, punts rheumatoid arthritis drug
Fierce Biotech
Tue, 09/2/14 - 11:21 am
Bristol-Myers Squibb
Alder Biopharma
rheumatoid arthritis
clazakizumab
Bristol-Myers Squibb signs development deal for rheumatoid arthritis drug with Alder Biopharma
Yahoo/AP
Tue, 11/10/09 - 09:00 am
Alder Biopharma
Bristol-Myers Squibb
rheumatoid arthritis